Relevance of a Telemedicine Monitoring in the Management of Depression

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Oct 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of telemedicine to help manage depression in patients who have been hospitalized for medical reasons. Specifically, researchers want to see if regular check-ins through telemedicine, added to standard care, can improve the symptoms of major depressive disorder (MDD) and help patients stick to their treatment plans after leaving the hospital. The hope is that this approach will lead to better responses to antidepressant medications and lower healthcare costs related to depression.

To participate in the trial, individuals must be at least 18 years old and have been diagnosed with a depressive episode. They should have been hospitalized and received a change in their depression treatment during their stay. However, some people may not be eligible, such as those with severe depression requiring more intensive psychiatric care or those with certain other conditions. If chosen to participate, patients can expect ongoing support through telemedicine, which uses technology to stay connected with their healthcare providers, helping them manage their symptoms and treatment more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Presence of DSM5 criteria for the diagnosis of a characterized depressive episode
• • Patient hospitalized in MCO with request for liaison psychiatry opinion whatever the hospitalization modality (full hospitalization, weekday hospitalization or day hospitalization)
• • Initiation, change of molecule or modification of a psychotropic treatment (antidepressant or anxiolytic) during MCO hospitalization by the liaison psychiatrist
• • Affiliated or entitled to a social security system (except AME)
• • Obtaining free, written and informed consent
• Exclusion Criteria:
• • Severity of the depressive episode incompatible with outpatient care and relevant to an indication for hospitalization in psychiatry
• • Patient is part of a psychiatric care program at the time of the selection visit
• • Presence of a mood disorder other than CDD
• • Reason for MCO hospitalization secondary to psychiatric disorders, in particular suicide attempts
• • MCO hospitalization prolonged beyond 3 weeks after initiation, change of molecule or modification of psychotropic treatment dosage
• • Psychiatric comorbidities assessed by psychiatrist, in particular addictions (excluding tobacco), delusional disorders, post-traumatic stress disorder, anxiety disorders (excluding GAD)
• • High suicidal risk at the screening visit assessed by psychiatrist
• • Presence of a non-psychiatric condition with a vital prognosis of less than 3 years
• • Contraindications to telemedicine (no internet access, major vision problems, major cognitive problems, marked impulsivity, clinical situation requiring information to be communicated in person, etc.)
• • Conditions making consent impossible (major cognitive disorders, etc.)
• • Deprived of liberty or under a protective measure (guardianship or under curatorship)
• • Pregnant woman
• • Refusal of the patient